Related News
Baby death toll rises to 7 as China bans Shenzhen hepatitis B vaccine
Online Edition
INFANT deaths after inoculation using the recombinant hepatitis B vaccine produced by the Shenzhen-based Biokangtai company have now risen to at least seven nationwide, Beijing Times reported.
The China Food and Drug Administration (CFDA) and the National Health and Family Planning Commission (NHFPC) on Friday jointly issued a circular to ban the use of the vaccine.
An official investigation is underway. An infant in Shenzhen who became sick just minutes after a hepatitis B vaccination and died an hour later was reported yesterday to possibly have been the fourth victim of vaccines produced by Biokangtai. The company has not said where vaccines may have been sold that came from the same batch as the Shenzhen baby received.
An average of around 50,000 Chinese are born every day, according to official estimates, and most get the hepatitis B injection shortly after birth.
Biokangtai, established in August 1988, has a 60 percent share of the market and sales of 10 million vaccines a year in China, according to The Time Weekly.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
